Blume Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25
| Closed | -$7.12K | – | 316 |
|
|
2023
Q2 | $7.12K | Sell |
25
-29
| -54% | -$8.26K | ﹤0.01% | 260 |
|
|
2023
Q1 | $15K | Buy |
54
+26
| +93% | +$7.23K | ﹤0.01% | 221 |
|
|
2022
Q4 | $7.75K | Hold |
28
| – | – | ﹤0.01% | 260 |
|
|
2022
Q3 | $7K | Sell |
28
-56
| -67% | -$14K | ﹤0.01% | 255 |
|
|
2022
Q2 | $17K | Buy |
84
+11
| +15% | +$2.23K | 0.01% | 221 |
|
|
2022
Q1 | $15K | Buy |
73
+45
| +161% | +$9.25K | ﹤0.01% | 231 |
|
|
2021
Q4 | $7K | Hold |
28
| – | – | ﹤0.01% | 264 |
|
|
2021
Q3 | $8K | Hold |
28
| – | – | ﹤0.01% | 261 |
|
|
2021
Q2 | $10K | Hold |
28
| – | – | ﹤0.01% | 235 |
|
|
2021
Q1 | $8K | Buy |
+28
| New | +$8K | ﹤0.01% | 228 |
|
|
2015
Q2 | – | Sell |
-110
| Closed | -$46K | – | 244 |
|
|
2015
Q1 | $46K | Buy |
110
+60
| +120% | +$25.1K | 0.03% | 135 |
|
|
2014
Q4 | $17K | Buy |
+50
| New | +$17K | 0.01% | 211 |
|